Even without accounting for the…
Even without accounting for the COVID-related declines that have punctuated [...]
Eli Lilly is going for gold at the…
Eli Lilly is going for gold at the Milano Cortina [...]
Neurology-focused patient…
Neurology-focused patient groups’ perception of the pharma industry’s corporate reputation [...]
Kimberly-Clark has placed an…
Kimberly-Clark has placed an ambitious bet on a troubled counterpart, [...]
Boosted again by strong sales of…
Boosted again by strong sales of Skyrizi and Rinvoq, AbbVie [...]
The American Academy of Pediatrics…
The American Academy of Pediatrics on Friday said it does [...]
Gilead’s long-acting…
Gilead’s long-acting pre-exposure prophylaxis med Yeztugo has garnered $54 million [...]
Takeda tightened its pipeline in…
Takeda tightened its pipeline in the third quarter. Innovent Biologics [...]
As Biogen continues to carve out…
As Biogen continues to carve out new markets for its [...]
With vaccine sales on the decline…
With vaccine sales on the decline across the industry, these [...]